FDA Inspection 1312374 — IQVIA
The FDA completed an inspection of IQVIA on April 2, 2026 in Reading. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 2, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Reading (United Kingdom)
Additional Details
Clinical BA/BE